Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 2/20 | 0.45 |
| ▸ | CTSK | P43235 | 2/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3807941 | 0.86 | KMT2A (0.48) | MLYCDNPC1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL3810771 | 0.84 | MLYCD (0.44) | MLYCDNPC1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL18113985 | 0.84 | MLYCD (0.44) | MLYCDNPC1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL3809728 | 0.84 | NPC1 (0.45) | NPC1RAB9APOLBLMNAKMT2A | |
| SCHEMBL21749700 | 0.81 | NPC1 (0.44) | MLYCDNPC1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL3807531 | 0.81 | NPC1 (0.44) | MLYCDNPC1RAB9ASMN1; SMN2TDP1 | |
| SCHEMBL3805814 | 0.78 | CTSL (0.48) | NPC1RAB9ASMN1; SMN2TDP1POLB | |
| SCHEMBL4086683 | 0.77 | SMN1; SMN2 (0.41) | MLYCDCTSKCTSSNPC1RAB9A | |
| SCHEMBL3809689 | 0.75 | LMNA (0.43) | POLBLMNA | |
| SCHEMBL15165764 | 0.75 | MAPT (0.42) | MLYCDNPC1RAB9ASMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281352-A1 | PROCESS FOR PRODUCTION OF ETHYLENEDIAMINE DERIVATIVES HAVING HALOGENATED CARBAMATE GROUP AND ACYL GROUP, AND INTERMEDIATES FOR PRODUCTION OF THE DERIVATIVES | MITSUI CHEMICALS, INC. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090281352-A1 | PROCESS FOR PRODUCTION OF ETHYLENEDIAMINE DERIVATIVES HAVING HALOGENATED CARBAMATE GROUP AND ACYL GROUP, AND INTERMEDIATES FOR PRODUCTION OF THE DERIVATIVES | MITSUI CHEMICALS, INC. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090281352-A1 | PROCESS FOR PRODUCTION OF ETHYLENEDIAMINE DERIVATIVES HAVING HALOGENATED CARBAMATE GROUP AND ACYL GROUP, AND INTERMEDIATES FOR PRODUCTION OF THE DERIVATIVES | MITSUI CHEMICALS, INC. (JP) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281352-A1 | PROCESS FOR PRODUCTION OF ETHYLENEDIAMINE DERIVATIVES HAVING HALOGENATED CARBAMATE GROUP AND ACYL GROUP, AND INTERMEDIATES FOR PRODUCTION OF THE DERIVATIVES | ASNS, GLUL, NAAA | MLYCD 1226/4885CTSK 737/4885CTSS 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.